Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 16, No 2 (2023) Methodological approach to the formation of the list of high-tech medical care types Abstract  similar documents
I. A. Zheleznyakova, O. A. Volkova, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, Yu. S. Zueva, I. A. Alexandrov, V. V. Omelyanovskiy
"... groups (DRGs), on the one hand, significantly expanded the availability of HTMC methods ..."
 
Vol 12, No 3 (2019) Diagnosis-related groups and payments for the treatment of malignant neoplasms in the model of 2019 Abstract  similar documents
D. V. Fedyaev , V. V. Omelyanovskiy , M. L. Lazareva , Yu. V. Seryapina, Yu. A. Ledovskikh
"... The article addresses the model of diagnosis-related groups (DRG) updated according to the new ..."
 
Vol 17, No 2 (2024) Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access Abstract  similar documents
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy
"... of diagnosis-related groups (DRGs) for cases of surgical medical care provided by laparoscopic access ..."
 
Vol 16, No 2 (2023) Improving the model of payment for medical care for chronic viral hepatitis C in the framework of the implementation of the Program of State Guarantees of Free Provision of Medical Care to Citizens for 2023 and for the planned period of 2024–2025 Abstract  similar documents
V. V. Omelyanovskiy, I. A. Zheleznyakova, A. V. Zuev, O. S. Plakhotnik, O. A. Volkova, L. M. Davydova, G. V. Trifonova, E. V. Semakova, E. A. Prokhorovich, A. S. Volkova
"... -related groups (DRG) with the use of interferon-containing drugs as etiotropic therapy, which has been ..."
 
Vol 17, No 4 (2024) Development of a classification of anesthetic management methods and protocols for calculating financial costs Abstract  similar documents
D. V. Lukyantseva, J. A. Agafonova, V. V. Omelyanovskiy, S. A. Kovaleva, D. V. Fedyaev, I. N. Pasechnik, V. V. Schukin, D. S. Blinov, A. B. Abrosimov
"... in the expense structure of medical services, diagnosis-related groups (DRGs), and high-tech medical care (HMC ..."
 
Vol 13, No 3 (2020) The review of the foreign experience on the financing of innovative medical technologies Abstract  similar documents
V. V. Omelyanovskiy, I. A. Zheleznyakova, T. P. Bezdenezhnykh, M. L. Lazareva, D. V. Fedyaev
"... -related groups (DRG) does not contribute to the implementation of innovations in the medical practice ..."
 
Vol 14, No 2 (2021) Medical care payment improvement within diagnosis-related groups of patients with severe asthma requiring biologic disease-modifying drugs by regional adaptation mechanism in the Moscow Region Abstract  similar documents
A. D. Ermolaeva, V. S. Krysanova, T. N. Ermolaeva, K. I. Polyakova, K. A. Kokushkin
"... drugs (bDMDs) within the constraints of diagnosis-related groups (DRGs) on the level of the Moscow ..."
 
Vol 15, No 1 (2022) Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation Abstract  similar documents
T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg
"... lower ICD implantation prices resulted in an average ICER drop by 13% compared to HTMC 2. Overall ..."
 
Vol 14, No 2 (2021) Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting Abstract  similar documents
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov
"... (DRG), except for cases with a maximum duration in a day hospital setting. An analysis of the RDC lists ..."
 
Vol 11, No 3 (2018) What is the role of antineoplastic drug safety in reimbursement decision making? Abstract  similar documents
A. S. Kolbin, A. A. Kurylev
"... , поданных для включения в ограничительные лекарственные перечни в Российской Федерации, в период с 2014 по ..."
 
Vol 17, No 3 (2024) Approaches to developing mechanisms for medical care centralization at the interterritorial level Abstract  similar documents
D. V. Fedyaev, F. S. Nikitin, S. A. Kovaleva, V. V. Omelyanovskiy
"... and diagnosis-related groups (DRGs) of diseases, which potentially require centralization were developed ..."
 
Vol 11, No 2 (2018) Regional adaptation of the federal model of reimbursement for medical assistance based on clinical statistical groups: hospitalization of patients in need of genetically enginered biological preparations Abstract  similar documents
M. V. Sura, T. N. Ignatova, N. S. Rudneva, Yu. N. Sukhanova, N. G. Ulyanova, A. S. Khudyaev, V. A. Shelyakin, D. V. Scherbakov
"... Модель финансирования медицинской помощи по клинико-статистическим группам (КСГ) в 2018 г ..."
 
Vol 13, No 3 (2020) The use of various genetically engineered biological drugs and selective immunosuppressants within the current provider-payment model of russian diagnosis-related groups Abstract  similar documents
E. V. Derkach, E. A. Pyadushkina, M. V. Avxentyeva, T. V. Boyarskaya, E. E. Yagnenkova, A. S. Mokrova, M. M. Maryanyan
"... Diagnosis-Related Groups (DRG) for the payment for biological therapy were created at the stage ..."
 
Vol 10, No 4 (2017) THE STATE GUARANTEES PROGRAM OF FREE MEDICAL CARE: APPROACHES TO STANDARDIZE THE COSTS OF MEDICAL CARE Abstract  similar documents
Yu. A. Ledovskikh, E. V. Semakova, M. V. Avksent’eva
 
Vol 9, No 1 (2016) REVIEW OF HEALTH SYSTEM ORGANIZATION APPROACHES TO ESTIMATING SERVICE LEVELS AND EXPENDITURES FOR INPATIENT CARE SERVICES Abstract  similar documents
K. V. Gerasimova, D. V. Fedyaev, M. V. Sura, A. A. Tikhonova, V. V. Omelyanovskiy, M. V. Avksentyeva
"... is based on per case of treatment for a relevant group of diseases (diagnosis related group (DRG ..."
 
Vol 14, No 1 (2021) Development of a method for the analysis of the lists of medicines and its application for the analysis of the lists of medicines in Russia, England, and Italy Abstract  similar documents
V. A. Lemeshko, K. I. Matrenin, V. V. Omelyanovskiy, Yu. V. Vasilyeva, G. R. Khachatryan, L. A. Kolganov
"... Цель: разработка и апробация методики сравнительного анализа перечней лекарственных препаратов (ЛП ..."
 
Vol 9, No 1 (2016) MATHEMATICAL MODEL OF REIMBURSEMENT DECISION MAKING IN RUSSIA. RESULTS OF VIM LIST FOR 2016 Abstract  similar documents
A. S. Kolbin, A. V. Prasolov, E. A. Maksimkina, Yu. E. Balykina, Z. M. Golant, Yu. S. Polushin, A. A. Kurylev, I. A. Vilyum
"... математические линейные модели. Цель. Построение модели по данным анализа перечней на 2016 г. Материалы и ..."
 
Vol 10, No 1 (2017) RESTRICTIVE LISTS OF DRUGS: REGULATIONS, FUNCTIONS, SOURCES OF FINANCE, AND GUIDELINES FOR CREATION Abstract  similar documents
M. V. Sura
"... , источники финансирования перечней лекарственных препаратов, оказывающих наиболее существенное влияние на ..."
 
Vol 13, No 2 (2020) Improvements to the formation of lists of drugs for medical use: analysis of changes in the Government Decree no. 871 Abstract  similar documents
V. V. Omelyanovskiy, E. A. Maksimkina, O. I. Ivakhnenko, M. V. Avxentyeva, M. V. Sura, G. R. Khachatryan
"... Совершенствование порядка формирования перечней лекарственных препаратов для медицинского ..."
 
Vol 11, No 3 (2018) The concept of multi-criteria analysis of decision-making in the current system of health technology assessment in Russia Abstract  similar documents
V. V. Omelyanovsky, V. K. Fedyaeva, N. Z. Musina
"... перспектив совершенствования принципов формирования ограничительных перечней в РФ. Сделано заключение о том ..."
 
Vol 11, No 4 (2018) Patient registers and account registries of compulsory medical insurance: integration and replaceability Abstract  similar documents
I. A. Zheleznyakova, G. I. Pirova, E. A. Proxorovich
 
Vol 8, No 2 (2015) PRINCIPLES OF IMPORT SUBSTITUTION REGARDING DRUGS Abstract  similar documents
Alana Viktorovna Dzaneva, Vitalii Vladimirovich Omel'yanovskii, Saniyat Aleksandrovna Kagermazova
"... ограничительных перечней на различных уровнях системы здравоохранения. В статье рассматривается методология ..."
 
Vol 9, No 3 (2016) EARLY HEALTH TECHNOLOGIES ASSESSMENT — NEW APPROACH TO IMPROVING THE EFFICIENCY OF THE MEDICAL TECHNOLOGY DEVELOPMENT PROCESS Abstract  similar documents
N. Z. Musina, V. V. Omelyanovskiy, A. V. Krasheninnikova
"... включения технологии (лекарственного препарата) в ограничительные перечни, а также определить приемлемую для ..."
 
Vol 11, No 4 (2018) Treatment of patients with malignant lymphoproliferative diseases in the Russian Federation: analysis of the data from 75 regions Abstract  similar documents
G. R. Hachatryan, T. S. Teptsova, V. A. Lemeshko, N. Z. Musina
"... анализе затрат на терапию по видам высокотехнологичной медицинской помощи (ВМП). Заключение. Таким образом ..."
 
Vol 13, No 2 (2020) Review of calculation methods, procedures for registration and re-registration of producer prices of medicines in the countries of the Eurasian Economic Union Abstract  similar documents
A. A. Leshkevich, D. S. Yurochkin, Z. M. Golant, I. A. Narkevich
"... ; сравнение перечня референтных стран, понижающих коэффициентов. Результаты. Выявлены различия в процедурах ..."
 
Vol 9, No 3 (2016) DRUGS PROVIDED TO BREAST CANCER PATIENTS WITHIN THE STATE PROGRAMS OF DRUG SUPPLY Abstract  similar documents
M. V. Avxentyeva, V. I. Bogin, E. V. Derkach, V. V. Omelyanovskiy, M. B. Stenina, A. V. Tarakanov, M. Yu. Frolov
"... препаратов, включенных и не включенных в стандарты медицинской помощи, перечни лекарственных препаратов ..."
 
Vol 18, No 2 (2025) Data analysis of medicines aimed at health technology assessment within the activities of the “Circle of Kindness” Foundation from 2021 to 2024 Abstract  similar documents
V. V. Omelyanovskiy, A. A. Kingshott, T. S. Teptsova, P. A. Mukhortova, A. G. Kharitonova, S. I. Zinadinov, L. O. Krekhtunova, N. A. Aldushchenko, A. А. Kozak, V. A. Ryagina
"... при принятии решений о включении заболеваний в перечень заболеваний и ЛП в перечни для закупок Фонда ..."
 
Vol 12, No 2 (2019) Health technology assessment and reimbursement of pharmaceuticals in Italy Abstract  similar documents
F. V. Gorkavenko, V. V. Omelyanovskiy, T. P. Bezdenezhnykh, G. R. Khachatryan
"... формирование национального перечня возмещаемых препаратов. В некоторых регионах Италии существуют собственные ..."
 
Vol 12, No 4 (2019) The health technology assessment system in Australia Abstract  similar documents
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
"... правительством, которое определяет перечни возмещаемых препаратов и медицинских услуг, а также устанавливает ..."
 
Vol 7, No 4 (2014) ROAD MAP FOR DEVELOPMENT OF PRICE REGULATION SYSTEM AND SYSTEM OF DRUG SUPPLY AT THE EXPENSE OF RUSSIAN FEDERATION HEALTHCARE SYSTEM FUNDS Abstract  similar documents
M. V. Sura, K. V. Gerasimova, V. V. Omelyanovskiy, M. V. Avksentieva
"... ценообразования. В ходе анализа цен на препараты из перечня ЖНВЛП выявлены существенные (до 25 раз) различия в ..."
 
Vol 10, No 1 (2017) BIOLOGICAL THERAPY IN ADULT PATIENTS WITH ULCERATIVE COLITIS AND CROHN’S DISEASE: BUDGET IMPACT ANALYSIS Abstract  similar documents
E. A. Pyadushkina
"... лекарственных препаратов (ЛП) из перечня жизненно необходимых и важнейших лекарственных препаратов (ПЖНВЛП ..."
 
Vol 16, No 3 (2023) Analysis of tariff agreements of the constituent entities of the Russian Federation: form and completeness of data presentation Abstract  similar documents
D. V. Fedyaev, F. S. Nikitin, T. N. Artamonova, S. A. Kovaleva, V. V. Omelyanovskiy
"... оплате медицинской помощи. Несмотря на наличие перечня требований к содержанию и структуре тарифного ..."
 
Vol 8, No 4 (2015) CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS Abstract  similar documents
E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
"... препаратов из перечня жизненно необходимых и важнейших лекарственных препаратов (ЖНВЛП), ориентировочная ..."
 
Vol 11, No 2 (2018) Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer Abstract  similar documents
G. V. Afonin, Yu. A. Ragulin, M. V. Avxentyeva, I. A. Gulidov, S. A. Ivanov, A. D. Kaprin
"... безрецидивной выживаемости. Выделены основные пункты в перечне медицинских услуг, влияющие на формирование ..."
 
Vol 9, No 3 (2016) CLINICAL AND ECONOMIC EVALUATION OF LACOSAMIDE IN PATIENTS WITH PARTIAL EPILEPSY Abstract  similar documents
E. A. Pyadushkina, M. Yu. Frolov
"... рассчитываются на основе зарегистрированных цен препаратов из перечня жизненно необходимых и важнейших ..."
 
Vol 18, No 2 (2025) Pharmacoeconomic study of oral anticancer therapy: results of combined ABC/VEN and frequency analysis Abstract  similar documents
J. A. Agafonova
"... соответствии с наличием содержащихся в них препаратов из Примерного перечня Всемирной организации ..."
 
1 - 36 of 36 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)